Inc., a provider of innovative microdroplet-based solutions for human health
and disease research, today announced the commercial release of its Sequence
Enrichment Solution for sales in North America.
In an announcement at the 2009 Advances in Genome Biology and Technology Conference
(AGBT), the company said it has begun accepting orders for the solution and
has started commercial production of the solution’s components for shipment
during the first quarter.
“This milestone represents the first commercialized application of our
exciting RainStormTM microdroplet-based technology platform,” said Chris
McNary, President and Chief Executive Officer of RainDance Technologies. “It
underscores the power of droplet-based biology to increase the depth of understanding
about biological problems and increase the pace of biomedical discovery.”
The RainDance Sequence Enrichment Solution incorporates RainStorm technology
for targeted sequencing applications of the human genome. It will enable the
high-resolution analysis of genetic variation between individuals within populations
at a level unmatched by current methodologies. The solution dramatically improves
sample uniformity and reduces the selection bias typically associated with targeted
The Sequence Enrichment Solution consists of the following components:
- The RDT 1000 system generates picoliter-volume discrete PCR reactions in
droplets at the unprecedented rate of 10 million per hour. It amplifies hundreds
to thousands of genomic loci with high specificity and uniformity.
- Custom-Order Content for DNA Primer Libraries will be available that enable
the amplification of hundreds to thousands of genomic loci in a single tube.
RainDance customers can design and order these libraries specifically for
their research applications.
- Sequence enrichment consumables kits, provide a complete workflow solution
for easy implementation in the laboratory.
The company also announced that comprehensive training and support services
are available to maximize the operating performance of the solution.
“This commercialization step is the culmination of a rigorous Early Access
Partner program that involved some of the world’s leading genomic research
institutions,” said McNary. “These organizations see the potential
of our Sequence Enrichment Solution to enhance the performance of their next-generation
sequencing platforms and accelerate their discovery process.”
RainDance also is presenting a workshop, “Enrichment of Genomic Loci
for Targeted Sequencing Applications,” at the AGBT Conference on February
6 to explain the application and benefits of its new technology in genomics
For sales information, contact firstname.lastname@example.org or call 781-861-6300.
The company said the Sequence Enrichment Solution will be available for purchase
in Europe later this year.